Industry Reports
Real-World Effectiveness And Safety of Teduglutide in Adult Short Bowel Syndrome: A Meta-analysis
Randomized clinical trials have demonstrated that teduglutide, a glucagon-like peptide-2 (GLP-2) analog, improves intestinal absorption in patients with short bowel syndrome (SBS) with parenteral...
News
Vetter Once Again Wins Axia Best Managed Companies Award
For the second time in a row, Vetter, a global leading contract development and manufacturing organization (CDMO), has won the Axia Best Managed Companies...
Press Releases
Greenphire Announces Strategic Growth Investment from Thoma Bravo
Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, announced that it has reached an agreement to...
Drug Research
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded...
Packaging & Labelling
LATAM Cargo Group collaborates with SkyCell to bring hybrid to South America’s pharma market
Fulfilling our mission to deliver medicine to all means shipping pharma products to remote and infrastructurally challenging environments across the world. With our hybrid...
Press Releases
MedPharm Announces Expansion of Formulation Development and Analytical Service Labs in the UK
MedPharm Ltd, the world leader in formulation development and analytical services for topical and transdermal products, is thrilled to announce a £1.5M investment into the refurbishment and expansion...
Press Releases
Roche’s Antibody Cocktail is now available in India, Cipla to market it pan-India
Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read